Where does Immunocore Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Immunocore Limited ranks #9,795 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Immunocore Limited hold?

Immunocore Limited holds 32 US utility patents granted between 2015 and 2025, spanning 8 technology areas.

What is Immunocore Limited's Innovation Score?

Immunocore Limited has an Innovation Score of 38.8 out of 100 (top 40% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Immunocore Limited focus on?

Immunocore Limited's top technology area is C07K (Peptides) with 28 patents, ranking #344 of 3,615 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Immunocore Limited's patent grant rate increasing or decreasing?

Immunocore Limited's recent grant velocity is +188% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Immunocore Limited's patents?

Immunocore Limited's patents average 15.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Immunocore Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Immunocore Limited

USPTO PatentsView assignee record - 32 granted patents across 8 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07K (Peptides).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Immunocore ranks #9,795 of 49,997 tracked US assignees by granted-patent volume, with 32 patents across 8 technology areas.

#9,795
of 49,997 US assignees by volume: Top 40%
by Innovation Score (38.8/100): 15.8
avg claims per patent: +188%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R9795 · Foreign Corporation #9,795 · 32 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 32 grants
UPPER-Q #9,795/49,997
PHOTO-FINISH Hubbell Lighting
CPC-NARROW C07K · 8 areas
INNOV-THIN 38.8/100
CLAIMS-RICH 15.8 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +188% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Hubbell Lighting, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Immunocore’s 38.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.1 pts (31%) Velocity 7.2 pts (19%) Breadth 10.0 pts (26%) Claim depth 9.5 pts (24%)

Qualcomm Incorporated · highest

85
Alere SAN Diego · near

39
Cynora · near

39
Immunocore · this assignee

39
Institute OF… · near

39
Tarsus Pharmaceuticals · near

39
3D Lighting… · lowest

7

What this shows Immunocore's Innovation Score is 38.8/100 (top 40% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Immunocore?

Each dot is one of Immunocore’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Immunocore’s own 15.8 claims/patent is ABOVE the 11.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Immunocore vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Immunocore's grants concentrate

Immunocore Limited is a focused PatentsView assignee: 8 CPC subclasses with 87.5% of grants classified under C07K (Peptides). Peak complete grant year is 2021 (6 grants) versus a trough of 1 in 2018. By volume, Immunocore sits between Hubbell Lighting, Inc. and Institut Pasteur DE Lille.

Immunocore's three-year grant acceleration

Immunocore Limited shows 13 grants in 2022–2024 against only 12 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Hubbell Lighting

32
Hydrapak

32
Hydro Aluminum Ro…

32
Imds

32
Innova Patent

32
Innovative Medica…

32
Insinkerator

32
Institut Pasteur…

32
Immunocore ◀

32

What this shows Immunocore holds 32 patents at rank #9,794, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Immunocore

By rank, the assignees closest to #9,794 in granted patent volume.

Leaders in C07K (Peptides)

Other assignees with the most granted patents in Immunocore's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Immunocore, neither rank-band nor same-CPC leaders (those blocks stay above). In C07K (Peptides), Immunocore ranks #344 of 3,615 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (39 here).

Alere SAN Diego, Inc. 39 Cynora GmbH 39 Institute OF Pharmacology AND Toxicology, Academy OF Military Medical Sciences 39 Tarsus Pharmaceuticals, Inc. 39

Immunocore's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

39 Top 40% higher than 60% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Immunocore Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	6.3%
2016	3	9.4%
2018	1	3.1%
2019	2	6.3%
2020	4	12.5%
2021	6	18.8%
2022	3	9.4%
2023	5	15.6%
2024	5	15.6%
2025partial year	1	3.1%

Which technologies does Immunocore Limited patent most?

C07K - Peptides 28

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 22

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 22

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 14

C40B - Combinatorial CHEMISTRY; Libraries, e.g. Chemical Libraries 6

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 3

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 2

G16C - Computational CHEMISTRY; CHEMOINFORMATICS; Computational Materials Science 2

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Immunocore Limited's patent record in context - here's where to go next.

Immunocore Limited's lead technology class is C07K (Peptides), 87.5% of its portfolio - see every assignee active in that class. Explore C07K
Ranked #9,795 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Immunocore Limited against Hubbell Lighting, Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 38.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.